These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31304685)

  • 41. In Vivo Assessment of Decellularized Porcine Myocardial Slice as an Acellular Cardiac Patch.
    Shah M; Kc P; Zhang G
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23893-23900. PubMed ID: 31188555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elastic 3D-Printed Hybrid Polymeric Scaffold Improves Cardiac Remodeling after Myocardial Infarction.
    Yang Y; Lei D; Huang S; Yang Q; Song B; Guo Y; Shen A; Yuan Z; Li S; Qing FL; Ye X; You Z; Zhao Q
    Adv Healthc Mater; 2019 May; 8(10):e1900065. PubMed ID: 30941925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal stem cells enhanced cardiac nerve sprouting via nerve growth factor in a rat model of myocardial infarction.
    Chen J; Zheng S; Huang H; Huang S; Zhou C; Hou J; Jiang J; Wang J; Wu W; Wang T
    Curr Pharm Des; 2014; 20(12):2023-9. PubMed ID: 23844741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization.
    Deng S; Zhou X; Ge Z; Song Y; Wang H; Liu X; Zhang D
    Int J Biochem Cell Biol; 2019 Sep; 114():105564. PubMed ID: 31276786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bi-layered polyurethane - Extracellular matrix cardiac patch improves ischemic ventricular wall remodeling in a rat model.
    D'Amore A; Yoshizumi T; Luketich SK; Wolf MT; Gu X; Cammarata M; Hoff R; Badylak SF; Wagner WR
    Biomaterials; 2016 Nov; 107():1-14. PubMed ID: 27579776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Myocardial Infarction with Gene-modified Mesenchymal Stem Cells in a Small Molecular Hydrogel.
    Wu Z; Chen G; Zhang J; Hua Y; Li J; Liu B; Huang A; Li H; Chen M; Ou C
    Sci Rep; 2017 Nov; 7(1):15826. PubMed ID: 29158523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy.
    Ciuffreda MC; Malpasso G; Chokoza C; Bezuidenhout D; Goetsch KP; Mura M; Pisano F; Davies NH; Gnecchi M
    Acta Biomater; 2018 Apr; 70():71-83. PubMed ID: 29341932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal stem cells and extracellular matrix scaffold promote muscle regeneration by synergistically regulating macrophage polarization toward the M2 phenotype.
    Qiu X; Liu S; Zhang H; Zhu B; Su Y; Zheng C; Tian R; Wang M; Kuang H; Zhao X; Jin Y
    Stem Cell Res Ther; 2018 Apr; 9(1):88. PubMed ID: 29615126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular imaging to monitor repair of myocardial infarction using genetically engineered bone marrow-derived mesenchymal stem cells.
    Shi S; Zhang M; Guo R; Miao Y; Zhang X; Li B
    Curr Gene Ther; 2015; 15(5):460-71. PubMed ID: 25892408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice.
    Xie DM; Li YL; Li J; Li Q; Lu G; Zhai Y; Zhang J; Huang Z; Gao X
    Stem Cell Res Ther; 2019 Nov; 10(1):331. PubMed ID: 31747966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An in vitro model for the assessment of stem cell fate following implantation within the infarct microenvironment identifies ISL-1 expression as the strongest predictor of c-Kit(+) cardiac progenitor cells' therapeutic potential.
    Sullivan KE; Burns LJ; Black LD
    J Mol Cell Cardiol; 2015 Nov; 88():91-100. PubMed ID: 26393440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of human mesenchymal stem cell function in a three-dimensional matrix promotes attenuation of adverse remodelling after myocardial infarction.
    Simpson DL; Dudley SC
    J Tissue Eng Regen Med; 2013 Mar; 7(3):192-202. PubMed ID: 22095744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
    Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
    Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paintable Decellularized-ECM Hydrogel for Preventing Cardiac Tissue Damage.
    Lee J; Lee SG; Kim BS; Park S; Sundaram MN; Kim BG; Kim CY; Hwang NS
    Adv Sci (Weinh); 2024 Jun; 11(21):e2307353. PubMed ID: 38502886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.
    Mias C; Lairez O; Trouche E; Roncalli J; Calise D; Seguelas MH; Ordener C; Piercecchi-Marti MD; Auge N; Salvayre AN; Bourin P; Parini A; Cussac D
    Stem Cells; 2009 Nov; 27(11):2734-43. PubMed ID: 19591227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transplantation of mesenchymal stem cells with self-assembling polypeptide scaffolds is conducive to treating myocardial infarction in rats.
    Cui XJ; Xie H; Wang HJ; Guo HD; Zhang JK; Wang C; Tan YZ
    Tohoku J Exp Med; 2010 Dec; 222(4):281-9. PubMed ID: 21139379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.